The first publication of Annex 1 can be traced back to 1971 where it then described the foundational elements to ensure sterility of commercialized medicinal products. Since that time Annex 1 has undergone a number of targeted updates but only recently has undergone a full review. After two rounds of targeted consultation, with the most recent being completed July 2020, industry now waits for the final publication which is anticipated mid 2022. The Annex 1 revision has far-reaching implications for many years to come.
The 2022 ISPE Aseptic Conference features the breakout session "Aseptic Group Discussions: Annex 1 Implementation: Challenges and Opportunities" that will explore both the challenges and opportunities faced with implementation, including inspection approaches/experiences as well as the application of QRM principles. Watch this video to hear from session leader and program committee member Michael Higgins, Senior Compliance Advisor, Genentech.
Membership will allow you to access this content and other similar content. Learn about membership today!
